Search Results - "McGill, Mitchell"

Refine Results
  1. 1

    The past and present of serum aminotransferases and the future of liver injury biomarkers by McGill, Mitchell R

    Published in EXCLI journal (01-01-2016)
    “…Laboratory testing is important in the diagnosis and monitoring of liver injury and disease. Current liver tests include plasma markers of injury (e.g…”
    Get full text
    Journal Article
  2. 2

    Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis by McGill, Mitchell R., Jaeschke, Hartmut

    Published in Pharmaceutical research (01-09-2013)
    “…ABSTRACT Acetaminophen (APAP) is one of the most widely used drugs. Though safe at therapeutic doses, overdose causes mitochondrial dysfunction and…”
    Get full text
    Journal Article
  3. 3

    The Role of Mechanistic Biomarkers in Understanding Acetaminophen Hepatotoxicity in Humans by McGill, Mitchell R

    Published in Drug metabolism and disposition (01-08-2024)
    “…Our understanding of the fundamental molecular mechanisms of acetaminophen (APAP) hepatotoxicity began in 1973 to 1974, when investigators at the US National…”
    Get full text
    Journal Article
  4. 4

    Animal models of drug-induced liver injury by McGill, Mitchell R., Jaeschke, Hartmut

    “…Drug-induced liver injury (DILI) presents unique challenges for consumers, clinicians, and regulators. It is the most common cause of acute liver failure in…”
    Get full text
    Journal Article
  5. 5

    Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity by Jaeschke, Hartmut, McGill, Mitchell R., Ramachandran, Anup

    Published in Drug metabolism reviews (01-02-2012)
    “…Hepatotoxicity is a serious problem during drug development and for the use of many established drugs. For example, acetaminophen overdose is currently the…”
    Get full text
    Journal Article
  6. 6

    The development and hepatotoxicity of acetaminophen: reviewing over a century of progress by McGill, Mitchell R., Hinson, Jack A.

    Published in Drug metabolism reviews (01-10-2020)
    “…Acetaminophen (APAP) was first synthesized in the 1800s, and came on the market approximately 65 years ago. Since then, it has become one of the most used…”
    Get full text
    Journal Article
  7. 7

    Hepatotoxicity due to herbal dietary supplements: Past, present and the future by Gurley, Bill J., McGill, Mitchell R., Koturbash, Igor

    Published in Food and chemical toxicology (01-11-2022)
    “…Dietary supplements (DS) constitute a widely used group of products comprising vitamin, mineral, and botanical extract formulations. DS of botanical or herbal…”
    Get full text
    Journal Article
  8. 8

    Acetaminophen-induced liver injury in rats and mice: Comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity by McGill, Mitchell R., Williams, C. David, Xie, Yuchao, Ramachandran, Anup, Jaeschke, Hartmut

    Published in Toxicology and applied pharmacology (01-11-2012)
    “…Acetaminophen (APAP) overdose is the most common cause of acute liver failure in the West. In mice, APAP hepatotoxicity can be rapidly induced with a single…”
    Get full text
    Journal Article
  9. 9

    The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation by McGill, Mitchell R, Sharpe, Matthew R, Williams, C David, Taha, Mohammad, Curry, Steven C, Jaeschke, Hartmut

    Published in The Journal of clinical investigation (01-04-2012)
    “…Acetaminophen (APAP) overdose is the predominant cause of acute liver failure in the United States. Toxicity begins with a reactive metabolite that binds to…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients by McGill, Mitchell R, Jaeschke, Hartmut

    “…Drug hepatotoxicity is a major clinical issue. Acetaminophen (APAP) overdose is especially common. Serum biomarkers used to follow patient progress reflect…”
    Get more information
    Journal Article
  13. 13

    Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase by Du, Kuo, Williams, C. David, McGill, Mitchell R., Jaeschke, Hartmut

    Published in Toxicology and applied pharmacology (15-11-2014)
    “…Acetaminophen (APAP) overdose causes severe hepatotoxicity in animals and humans. However, the mechanisms underlying the gender differences in susceptibility…”
    Get full text
    Journal Article
  14. 14

    Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen‐induced hepatocyte necrosis in mice by Ramachandran, Anup, McGill, Mitchell R., Xie, Yuchao, Ni, Hong‐Min, Ding, Wen‐Xing, Jaeschke, Hartmut

    Published in Hepatology (Baltimore, Md.) (01-12-2013)
    “…Acetaminophen (APAP) overdose is a major cause of hepatotoxicity and acute liver failure in the U.S., but the pathophysiology is incompletely understood…”
    Get full text
    Journal Article
  15. 15

    Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model by Ewing, Laura E, Skinner, Charles M, Quick, Charles M, Kennon-McGill, Stefanie, McGill, Mitchell R, Walker, Larry A, ElSohly, Mahmoud A, Gurley, Bill J, Koturbash, Igor

    Published in Molecules (Basel, Switzerland) (30-04-2019)
    “…The goal of this study was to investigate Cannabidiol (CBD) hepatotoxicity in 8-week-old male B6C3F mice. Animals were gavaged with either 0, 246, 738, or 2460…”
    Get full text
    Journal Article
  16. 16

    Mechanisms of acetaminophen-induced cell death in primary human hepatocytes by Xie, Yuchao, McGill, Mitchell R., Dorko, Kenneth, Kumer, Sean C., Schmitt, Timothy M., Forster, Jameson, Jaeschke, Hartmut

    Published in Toxicology and applied pharmacology (15-09-2014)
    “…Acetaminophen (APAP) overdose is the most prevalent cause of drug-induced liver injury in western countries. Numerous studies have been conducted to…”
    Get full text
    Journal Article
  17. 17

    Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis by Ward, Jeanine, Kanchagar, Chitra, Veksler-Lublinsky, Isana, Lee, Rosalind C, McGill, Mitchell R, Jaeschke, Hartmut, Curry, Steven C, Ambros, Victor R

    “…We have identified, by quantitative real-time PCR, hundreds of miRNAs that are dramatically elevated in the plasma or serum of acetaminophen (APAP) overdose…”
    Get full text
    Journal Article
  18. 18

    Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans by Williams, C. David, Bajt, Mary Lynn, Sharpe, Matthew R., McGill, Mitchell R., Farhood, Anwar, Jaeschke, Hartmut

    Published in Toxicology and applied pharmacology (01-03-2014)
    “…Following acetaminophen (APAP) overdose there is an inflammatory response triggered by the release of cellular contents from necrotic hepatocytes into the…”
    Get full text
    Journal Article
  19. 19

    Biomarkers of drug-induced liver injury by McGill, Mitchell R, Jaeschke, Hartmut

    Published in Advances in pharmacology (1990) (2019)
    “…Drug-induced liver injury (DILI) is a major clinical and regulatory challenge. As a result, interest in DILI biomarkers is growing. So far, considerable…”
    Get more information
    Journal Article
  20. 20

    Current issues with acetaminophen hepatotoxicity—A clinically relevant model to test the efficacy of natural products by Jaeschke, Hartmut, McGill, Mitchell R., Williams, C. David, Ramachandran, Anup

    Published in Life sciences (1973) (25-04-2011)
    “…There is a significant need to evaluate the therapeutic potential of natural products and other compounds purported to be hepatoprotective…”
    Get full text
    Journal Article